Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study
IntroductionPemphigus encompasses a group of muco-cutaneous autoimmune bullous diseases characterized by the loss of adhesion between keratinocytes. The disease is associated with increased morbidity and mortality.Materials and MethodsWe characterized clinical patterns, survival, comorbidities, and...
Main Authors: | Lavinia Quintarelli, Alessio Coi, Roberto Maglie, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, Valentina Ruffo di Calabria, Alice Verdelli, Beatrice Bianchi, Elena Del Bianco, Emiliano Antiga, Marzia Caproni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.895490/full |
Similar Items
-
Case Report: Management of Malignancy-Exacerbated Pemphigus Vulgaris During COVID-19 Pandemic
by: Alberto Corrà, et al.
Published: (2021-08-01) -
An update on the management of refractory cutaneous lupus erythematosus
by: Alice Verdelli, et al.
Published: (2022-09-01) -
B-cell depletion in the treatment of pemphigus: two clinical cases and literature review
by: Oleg V. Karzanov, et al.
Published: (2023-02-01) -
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease
by: Maria Efenesia Baffa, et al.
Published: (2022-07-01) -
Rituximab treatment of pemphigus in women of childbearing age: experience with two patients
by: Eden P. Lake, et al.
Published: (2017-11-01)